Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2019 Filed May 14, 2019 21:25 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000113 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,820.567 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 35.558 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:23 UTC |
BOUDREAUX GAILDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000110 · edgar.xml · derivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,363.881 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:23 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000110 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,490.032 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 17.300 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:24 UTC |
GLASSCOCK LARRY CDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,467.934 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:24 UTC |
GLASSCOCK LARRY CDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000112 · edgar.xml · derivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,693.237 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 172.336 phantom stock units accrued between July 31, 2018 and April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:23 UTC |
Farrell Michael J.Director
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000111 · edgar.xml · derivative · entry 2 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,596.778 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:23 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000111 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,362.609 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 11.154 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:21 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,363.881 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:21 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000107 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,152.912 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.351 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:22 UTC |
BERNARD BETSY JDirector
|
GrantRestricted Stock Units · Derivative | 1,078.122 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000109 · edgar.xml · derivative · entry 2 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,022.258 Underlying: Common Stock · 1,078.122 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 10, 2019 Filed May 14, 2019 21:22 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $120.58 | $0.00 |
DisclosureSEC source: 0000911916-19-000109 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,292.638 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 20.784 phantom stock units accrued on April 30, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 08, 2019 Filed Jun 20, 2019 20:51 UTC |
Florin Daniel PExec. VP, CFO
|
GiftCommon Stock | 239 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000137 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,471 F1 · kind: This transaction involved a gift of securities by the reporting person and is being voluntarily reported earlier than required. Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:18 UTC |
Tornos IvanGroup President, Orthopedics
|
Exercise / conversionRestricted Stock Units · Derivative | 8,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000105 · edgar.xml · derivative · entry 3 Tornos Ivan · CIK 0001757216 · Group President, Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,140 shares Expires 2019-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:18 UTC |
Tornos IvanGroup President, Orthopedics
|
Tax withholdingCommon Stock | 2,834 | $124.30 | $352,266.20 |
DisclosureSEC source: 0000911916-19-000105 · edgar.xml · nonDerivative · entry 2 Tornos Ivan · CIK 0001757216 · Group President, Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,306 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units. Read SEC document |
| May 03, 2019 Filed May 7, 2019 20:18 UTC |
Tornos IvanGroup President, Orthopedics
|
Exercise / conversionCommon Stock | 8,140 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000105 · edgar.xml · nonDerivative · entry 1 Tornos Ivan · CIK 0001757216 · Group President, Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:04 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 186.67 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000103 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,913.9 Underlying: Common Stock · 186.67 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 9.901 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:00 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 216.144 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000097 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,771.854 Underlying: Common Stock · 216.144 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 22.652 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:04 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 216.144 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000101 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,897.238 Underlying: Common Stock · 216.144 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 49.345 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:00 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 314.695 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,634.561 Underlying: Common Stock · 314.695 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:04 UTC |
Hilado Maria TeresaDirector
|
GrantPhantom Stock Units · Derivative | 186.67 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000102 · edgar.xml · derivative · entry 1 Hilado Maria Teresa · CIK 0001587868 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 598.522 Underlying: Common Stock · 186.67 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: 93.335 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes .401 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:03 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 225.969 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000100 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,285.009 Underlying: Common Stock · 225.969 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 39.144 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:03 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 186.67 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000099 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,851.455 Underlying: Common Stock · 186.67 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 11.965 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 23:01 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 186.67 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000098 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,972.732 Underlying: Common Stock · 186.67 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 18.836 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 21:28 UTC |
Jafry Syed A.Director
|
GrantPhantom Stock Units · Derivative | 93.335 | $0.00 Strike: $127.23 | $0.00 |
DisclosureSEC source: 0000911916-19-000094 · edgar.xml · derivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299.262 Underlying: Common Stock · 93.335 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes .201 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 23:00 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 98.551 | $0.00 Strike: $115.47 | $0.00 |
DisclosureSEC source: 0000911916-19-000096 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,319.866 Underlying: Common Stock · 98.551 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned. F4 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.underlying_shares: Represents phantom stock units credited to the reporting person under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors, as units earned but not credited for committee chair fees in 2018 and related units for dividend payments following the date the units were earned. F5 · balance_after: Includes 19.794 phantom stock units accrued on January 31, 2019 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:15 UTC |
Yi SangPresident, Asia Pacific
|
Exercise / conversionRestricted Stock Units · Derivative | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000084 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:15 UTC |
Yi SangPresident, Asia Pacific
|
Exercise / conversionCommon Stock | 1,443 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000084 · edgar.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 426 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and December 31, 2018. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 1,331 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000082 · edgar.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,331 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F4 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Tax withholdingCommon Stock | 381 | $127.03 | $48,398.43 |
DisclosureSEC source: 0000911916-19-000082 · edgar.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,473 F2 · shares: Represents shares withheld by the Company to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 1,331 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000082 · edgar.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 265 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan and pursuant to dividend reinvestment between October 31, 2018 and January 31, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Hanson Bryan CDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 7,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000080 · edgar.xml · derivative · entry 3 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,872 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Hanson Bryan CDirector · President and CEO
|
Tax withholdingCommon Stock | 3,649 | $127.03 | $463,532.47 |
DisclosureSEC source: 0000911916-19-000080 · edgar.xml · nonDerivative · entry 2 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,438 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:14 UTC |
Hanson Bryan CDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,872 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000080 · edgar.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC |
Florin Daniel PExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 2,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · derivative · entry 4 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F4 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC |
Florin Daniel PExec. VP, CFO
|
Tax withholdingCommon Stock | 749 | $127.03 | $95,145.47 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 3 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,710 F2 · shares: Represents shares withheld by the Company to satisfy tax withholing oblications on the vesting of restricted stock units ("RSU"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:13 UTC |
Florin Daniel PExec. VP, CFO
|
Exercise / conversionCommon Stock | 2,551 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC |
Bruneau AureGroup President
|
Exercise / conversionRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · derivative · entry 3 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: Earned RSUs vested on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs vested on March 20, 2019. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC |
Bruneau AureGroup President
|
Tax withholdingCommon Stock | 163 | $127.03 | $20,705.89 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 2 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757 F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 20:12 UTC |
Bruneau AureGroup President
|
Exercise / conversionCommon Stock | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000076 · edgar.xml · nonDerivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 12, 2019 Filed Mar 22, 2019 20:13 UTC |
Florin Daniel PExec. VP, CFO
|
GiftCommon Stock | 490 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000078 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,908 F1 · balance_after: Includes 72 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2018 and December 31, 2018. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 21:32 UTC |
Jafry Syed A.Director
|
PurchaseCommon Stock | 1,925 | $125.52 | $241,623.88 |
DisclosureSEC source: 0000911916-19-000068 · edgar.xml · nonDerivative · entry 1 Jafry Syed A. · CIK 0001745891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:30 UTC |
Bruneau AureGroup President
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,446 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000061 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,446 Underlying: Common Stock · 10,446 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:33 UTC |
Yi SangPresident, Asia Pacific
|
GrantEmployee Stock Option (right to buy) · Derivative | 26,116 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000067 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,116 Underlying: Common Stock · 26,116 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:33 UTC |
Tornos IvanGroup President, Orthopedics
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,045 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000066 · edgar.xml · derivative · entry 1 Tornos Ivan · CIK 0001757216 · Group President, Orthopedics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,045 Underlying: Common Stock · 40,045 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:32 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
GrantEmployee Stock Option (right to buy) · Derivative | 23,940 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000065 · edgar.xml · derivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,940 Underlying: Common Stock · 23,940 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:32 UTC |
Hanson Bryan CDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 144,501 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000064 · edgar.xml · derivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,501 Underlying: Common Stock · 144,501 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:31 UTC |
Florin Daniel PExec. VP, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 40,045 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000063 · edgar.xml · derivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,045 Underlying: Common Stock · 40,045 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 21:30 UTC |
Deltort DidierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,375 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0000911916-19-000062 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,375 Underlying: Common Stock · 24,375 shares Expires 2029-02-26 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 26, 2020. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 11:03 UTC |
HIGGINS ARTHUR JDirector
|
PurchaseCommon Stock | 500 | $123.28 | $61,637.65 |
DisclosureSEC source: 0000911916-19-000036 · edgar.xml · nonDerivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Read SEC document |
| February 15, 2019 Filed Feb 20, 2019 21:36 UTC |
Bruneau AureGroup President
|
GrantRestricted Stock Units · Derivative | 666 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-19-000047 · edgar.xml · derivative · entry 1 Bruneau Aure · CIK 0001725831 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666 Underlying: Common Stock · 666 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on March 20, 2019. F3 · derivative.expiration_date: Earned RSUs will vest on March 20, 2019. F2 · derivative.underlying_shares: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. F2 · balance_after: On March 20, 2018, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2018 - 2020, with an opportunity for interim payouts after 2018 and 2019 depending on actual performance. As determined on February 15, 2019, based on actual performance for 2018, the reporting person earned 666 RSUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.